Nearly half of young New Yorkers statewide are still missing the mark on standardized math and English exams, according to newly released data. The state Education Department released its yearly ...

Inside OpenAI’s $1.4 Trillion Bet: Foxconn Factories and the Stargate Data Center Race Your email has been sent OpenAI has tapped the iPhone manufacturing giant Foxconn to design and build artificial ...

The longstanding public health practice of adding fluoride to community drinking water is facing heavy scrutiny in the United States over questions about whether the benefits outweigh the potential ...

Vertiv Chairman Dave Cote joins 'Squawk on the Street' to discuss why he expects AI-driven data-center growth to remain positive for at least five years, how machine-to-machine AI is beginning to ...

The analysis also examines water use and offers a road map for lower emissions through states with considerable renewable resources. The U.S. data center boom could spike carbon emissions through the ...

The Minnesota Vikings may have gotten their 2025 season back on track when they beat the Detroit Lions on Sunday. Their 27-24 victory got them to 4-4 after a season full of injuries and inconsistency.

A new study hints that age-related changes in our brains may explain why time feels like it's slipping away faster with every passing year. When you purchase through links on our site, we may earn an ...

Background: Medical students’ work engagement (MSWE) is widely considered an essential indicator of their state of mind, affecting their productivity and future career development as doctors. In our ...

-Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy- -As of the August 31, 2025 data cut-off date, all seven ...

High school seniors had the worst reading scores since 1992 on a national test, a loss probably related to increases in screen time and the pandemic. Their math scores fell as well. By Dana Goldstein ...

Positive topline results from two phase 3 trials reported this week may expand the treatment landscape for generalized myasthenia gravis (gMG), a rare autoimmune disease marked by debilitating muscle ...